XML 17 R3.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS) [Abstract]      
Revenue $ 368,554 $ 333,342 $ 394,661
Cost of revenue (290,745) (250,090) (153,255)
Gross profit 77,809 83,252 241,406
Selling expenses (8,246) (11,683) (8,448)
General and administrative expenses (66,454) (93,453) (89,735)
Research and development expenses (29,534) (35,430) (29,501)
Listing fee (33,151) 0 0
Other operating income / (expenses) 3,791 (3,628) 14,625
Other net gain 3,538 357 [1] 2,483
Profit / (loss) from operations (52,247) (60,585) 130,830
Finance income / (expenses) 1,276 (4,181) 59
Profit / (loss) before taxation (50,971) (64,766) 130,889
Income tax benefit / (expense) (5,685) 4,400 (48,246)
Profit / (loss) for the year (56,656) (60,366) 82,643
Item that may be reclassified to profit or loss      
Exchange differences on translation of financial statements (26) (22) (195)
Other comprehensive loss for the year, net of tax (26) (22) (195)
Total comprehensive income / (loss) for the year $ (56,682) $ (60,388) $ 82,448
Earnings / (loss) per share      
Basic earnings / (loss) per share (in dollars per share) [2] $ (0.51) $ (0.56) $ 0.76
Diluted earnings / (loss) per share (in dollars per share) [2] $ (0.51) $ (0.56) $ 0.75
Weighted average number of shares outstanding (thousand shares)      
Weighted average number of shares outstanding - basic (in shares) [2],[3] 110,494 108,681 108,681
Weighted average number of shares outstanding - diluted (in shares) [2] 110,494 108,681 111,243
[1] The Group signed a project investment agreement with a third party in April 2021 and made a payment of approximately $2 million. The project was later forfeited, and the Group is actively collecting the paid amount, which was impaired as of June 30, 2021 based on management’s estimate over the likelihood of collection at current stage.
[2] After giving the effects of the reverse recapitalization completed in April 2023 as described in Note 1.
[3] The weighted average number of ordinary shares outstanding for the years ended December 31, 2022 and 2021 was retrospectively adjusted to reflect the reverse recapitalization effectuated in April 2023. See Note 1